![]() In HHS Region 1, which includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont, the CDC said Omicron's prevalence was 82.4%. More than 91 million live in US counties with. In HHS Region 7, which spans Iowa, Kansas, Missouri and Nebraska, Omicron is now estimated to make up 77.4% of new infections through New Year's Day. One study suggests the Delta variant may transmit faster than other strains because it makes more copies of itself inside our bodies at a faster rate. The state documented 543 new COVID-19 cases on Thursday in a 48 percent. However, the CDC's new estimates suggest the share of cases that would benefit from those monoclonal antibody drugs is quickly shrinking in every part of the country. Nevada has seen its COVID-19 case count skyrocket since mid-June, reaching Missouri’s levels in a few weeks. Some scientists had speculated early in Omicron's rise that the U.S. The Biden administration recently lifted curbs on the distribution of monoclonal antibodies from Regeneron and Eli Lilly, pointing to "significant variability" in Omicron's prevalence around the country and new guidelines published by the National Institutes of Health on prioritizing limited supplies of the drugs. Of the monoclonal antibody treatments currently authorized for COVID-19, only two drugs - one made by AstraZeneca and one from GlaxoSmithKline and Vir Biotechnology - appear to remain effective against Omicron. "Just by sheer numbers, we're going to get a lot of hospitalizations," warned Truelove.Īlso complicating the battle against Omicron: Doctors are facing a shortage of COVID-19 drugs that will work against the highly-mutated variant. Truelove has helped lead the consortium's work to coordinate modeling work from across several teams in projecting coming waves of the virus.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |